Drug Development Pipeline
Restore CFTR Function
This program is studying ABBV-191, a type of CFTR modulator called a potentiator.
Once CFTR protein reaches the cell surface, potentiators help facilitate the opening of the chloride channel to allow chloride and sodium (salt) to move in and out of the cell. This helps maintain the right balance of salt and water on the airway surface.
Laboratory studies to develop and test this compound are underway.
This program is sponsored by AbbVie and partially funded by the Cystic Fibrosis Foundation.
Sign up for clinical trial alerts
Get email updates about clinical trials that matter to you.
Explore clinical trials
Be a part of the movement transforming the future of cystic fibrosis treatment.Learn More